Jigar Raythatha

Jigar holds an M.B.A. from Columbia Business School and a B.A. in molecular biology and biochemistry and economics from Rutgers University.

Jigar has spent nearly 20 years in the biotechnology industry in a variety of business functions. As CEO of Constellation Pharmaceuticals, Jigar leads a company focused on harnessing its deep scientific expertise in cancer epigenetics to advance two ongoing clinical programs. 

​

Jigar rejoined Constellation in 2017 from Jounce Therapeutics, where was chief business officer. As the first employee at Jounce, he helped build the company from its inception to a 100-person, publicly traded R&D organization. 

​

Before Jounce, Jigar had an earlier tenure at Constellation, serving as head of corporate development, leading business development, strategy, and program and alliance management functions. 

​

Earlier, Jigar worked with Red Abbey Venture Partners, initially as a Kauffman Fellow, later as a principal and finally a venture partner. Earlier in his career, he held roles at Biogen and A.T. Kearney.

Jigar is a member of KFP Class 10, and served his fellowship at Red Abbey under the mentorship of Matt Zuga.